These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 442016)

  • 21. Platelet factor 3 in membranes and granules of human platelets.
    Farská I; Pudlák P; Posedĕlová H
    Acta Univ Carol Med Monogr; 1972; 53():141-6. PubMed ID: 4670726
    [No Abstract]   [Full Text] [Related]  

  • 22. Human platelet basic protein associated with antiheparin and mitogenic activities: purification and partial characterization.
    Paul D; Niewiarowski S; Varma KG; Rucinski B; Rucker S; Lange E
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5914-8. PubMed ID: 6934522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of granular heterogeneity in blood platelets by controlled digitonin-induced cell lysis.
    Akkerman JW; Niewiarowski S; Holmsen H
    Thromb Res; 1980 Jan 1-15; 17(1-2):249-54. PubMed ID: 7376132
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms of 5-hydroxytryptamine storage in subcellular organelles of blood platelets.
    Da Prada M; Pletscher A
    Adv Biochem Psychopharmacol; 1974; 10():311-20. PubMed ID: 4276957
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-binding platelet proteins demonstrated by crossed affinity immunoelectrophoresis.
    Gogstad GO; Solum NO; Krutnes MB
    Br J Haematol; 1983 Apr; 53(4):563-73. PubMed ID: 6299323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of a heparin-neutralizing protein from guinea-pig platelets and its comparison with human platelet factor 4.
    Maguire ED; Wallis RB
    Biochem Soc Trans; 1980 Dec; 8(6):726. PubMed ID: 7461265
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of circulating human platelet fragments by using monoclonal antibodies against platelet glycoprotein IIb-IIIa complex.
    Vos JJ; Huisman JG; Modderman PW; von dem Borne AE
    Br J Haematol; 1987 Apr; 65(4):447-50. PubMed ID: 3580301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine platelet antiheparin protein: platelet factor 4.
    Ciaglowski RE; Snow JW; Walz DA
    Ann N Y Acad Sci; 1981; 370():668-79. PubMed ID: 6943975
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of antiheparin activity of serum and platelet factor 4.
    Sear CH; Poller L
    J Clin Pathol; 1972 Nov; 25(11):1007. PubMed ID: 4648526
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiheparin activity of human serum and platelet factor 4.
    Sear CH; Poller L
    Thromb Diath Haemorrh; 1973 Sep; 30(1):93-105. PubMed ID: 4806356
    [No Abstract]   [Full Text] [Related]  

  • 31. Presence of antiheparin/platelet factor 4 immunoglobulin g is associated with poor prognosis in patients with suspected disseminated intravascular coagulation.
    Park JH; Kim JE; Kim HK; Han KS
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):66-71. PubMed ID: 23698726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP of blood platelets: accumulation in organelles storing 5-hydroxytryptamine and ATP.
    da Prada M; Burkard WP; Pletscher A
    Experientia; 1972 Jul; 28(7):845-6. PubMed ID: 4349021
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules.
    Giddings JC; Brookes LR; Piovella F; Bloom AL
    Br J Haematol; 1982 Sep; 52(1):79-88. PubMed ID: 6810914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic studies of proteins associated with subcellular fractions of normal human platelets.
    Nachman RL; Marcus AJ; Zucker-Franklin D
    J Lab Clin Med; 1967 Apr; 69(4):651-8. PubMed ID: 6020701
    [No Abstract]   [Full Text] [Related]  

  • 35. Subcellular localization of reserpine and 5-hydroxytryptamine in blood platelets after reserpine-induced release.
    Minter B; Crawford N
    Biochem J; 1968 Sep; 109(3):42P-43P. PubMed ID: 5685871
    [No Abstract]   [Full Text] [Related]  

  • 36. Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates.
    Ahmad S; Jeske WP; Walenga JM; Aldabbagh A; Iqbal O; Fareed J
    Thromb Res; 2000 Oct; 100(1):47-54. PubMed ID: 11053616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents.
    Corash L; Costa JL; Shafer B; Donlon JA; Murphy D
    Blood; 1984 Jul; 64(1):185-93. PubMed ID: 6234035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
    Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC; Genton E; Turpie AG
    Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutralization of antithrombin VI (fibrinogen breakdown products) with platelet antiheparin factor (platelet factor 4).
    Niewiarowski S; Farbiszewski R; Poplawski A
    Thromb Diath Haemorrh; 1965 Nov; 14(3-4):490-9. PubMed ID: 5006847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.